BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/85/0.1/20.12.24 | Real-time Bid/Ask 10:50:49 04/07/2024 BST | ||
| 0.36 EUR / 0.38 EUR | +5.71% |
|
| Current month | +6.06% | ||
| 1 month | -32.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 04/07/24 | 0.37 | +5.71% |
| 03/07/24 | 0.35 | -12.50% |
| 02/07/24 | 0.4 | +17.65% |
| 01/07/24 | 0.34 | +3.03% |
| 28/06/24 | 0.33 | -13.16% |
Delayed Quote Börse Stuttgart
Last update July 04, 2024 at 07:17 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD49CA |
| ISIN | DE000VD49CA8 |
| Date issued | 29/04/2024 |
| Strike | 85 $ |
| Maturity | 20/12/2024 (170 Days) |
| Parity | 10 : 1 |
| Emission price | 0.58 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.67 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.02 € |
| Spread % | 5.26% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
